Cargando…

DHFR-mediated effects of methotrexate in medulloblastoma and osteosarcoma cells: The same outcome of treatment with different doses in sensitive cell lines

Although methotrexate (MTX) is the most well-known antifolate included in many standard therapeutic regimens, substantial toxicity limits its wider use, particularly in pediatric oncology. Our study focused on a detailed analysis of MTX effects in cell lines derived from two types of pediatric solid...

Descripción completa

Detalles Bibliográficos
Autores principales:	NERADIL, JAKUB, PAVLASOVA, GABRIELA, SRAMEK, MARTIN, KYR, MICHAL, VESELSKA, RENATA, STERBA, JAROSLAV
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391593/ https://www.ncbi.nlm.nih.gov/pubmed/25739012 http://dx.doi.org/10.3892/or.2015.3819

Ejemplares similares

Non-DHFR-mediated effects of methotrexate in osteosarcoma cell lines: epigenetic alterations and enhanced cell differentiation
por: Sramek, Martin, et al.
Publicado: (2016)

The ATRA-induced differentiation of medulloblastoma cells is enhanced with LOX/COX inhibitors: an analysis of gene expression
por: Chlapek, Petr, et al.
Publicado: (2014)

Phospho-Protein Arrays as Effective Tools for Screening Possible Targets for Kinase Inhibitors and Their Use in Precision Pediatric Oncology
por: Neradil, Jakub, et al.
Publicado: (2019)

Atypical nuclear localization of CD133 plasma membrane glycoprotein in rhabdomyosarcoma cell lines
por: NUNUKOVA, ALENA, et al.
Publicado: (2015)

Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a PDGFRB Mutation Associated with Infantile Myofibromatosis
por: Sramek, Martin, et al.
Publicado: (2018)

Uniformity under in vitro conditions: Changes in the phenotype of cancer cell lines derived from different medulloblastoma subgroups
por: Chlapek, Petr, et al.
Publicado: (2017)

Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines
por: Veselska, Renata, et al.
Publicado: (2008)

The power of natural phenolic compounds: caffeic acid is able to enhance the retinoid-induced differentiation of tumor cells
por: Veselska, Renata, et al.
Publicado: (2014)

Individualization of Treatment Improves the Survival of Children With High-Risk Solid Tumors: Comparative Patient Series Analysis in a Real-Life Scenario
por: Kyr, Michal, et al.
Publicado: (2019)

Enhanced Antiproliferative Effect of Combined Treatment with Calcitriol and All-Trans Retinoic Acid in Relation to Vitamin D Receptor and Retinoic Acid Receptor α Expression in Osteosarcoma Cell Lines
por: Paukovcekova, Silvia, et al.
Publicado: (2020)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

Nestin as a marker of cancer stem cells
por: Neradil, Jakub, et al.
Publicado: (2015)

Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy
por: Veselska, Renata, et al.
Publicado: (2019)

Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms
por: Paukovcekova, Silvia, et al.
Publicado: (2020)

Serial Xenotransplantation in NSG Mice Promotes a Hybrid Epithelial/Mesenchymal Gene Expression Signature and Stemness in Rhabdomyosarcoma Cells
por: Skoda, Jan, et al.
Publicado: (2020)

Nestin expression in the cell lines derived from glioblastoma multiforme
por: Veselska, Renata, et al.
Publicado: (2006)

Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors
por: Paukovcekova, Silvia, et al.
Publicado: (2022)

Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy – Observational prospective single institution analysis
por: Múdry, Peter, et al.
Publicado: (2021)

Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene
por: Mudry, Peter, et al.
Publicado: (2017)

DHFR and MDR1 upregulation is associated with chemoresistance in osteosarcoma stem-like cells
por: Lee, Yu-Hsien, et al.
Publicado: (2017)

Identification of genes associated with methotrexate resistance in methotrexate-resistant osteosarcoma cell lines
por: Yang, Xiao-rong, et al.
Publicado: (2015)

Thiosemicarbazones and selected tyrosine kinase inhibitors synergize in pediatric solid tumors: NDRG1 upregulation and impaired prosurvival signaling in neuroblastoma cells
por: Krchniakova, Maria, et al.
Publicado: (2022)

NANOG/NANOGP8 Localizes at the Centrosome and is Spatiotemporally Associated with Centriole Maturation
por: Mikulenkova, Erika, et al.
Publicado: (2020)

Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration
por: Krchniakova, Maria, et al.
Publicado: (2020)

Iron-Chelation Treatment by Novel Thiosemicarbazone Targets Major Signaling Pathways in Neuroblastoma
por: Macsek, Peter, et al.
Publicado: (2021)

Co-Expression of Cancer Stem Cell Markers Corresponds to a Pro-Tumorigenic Expression Profile in Pancreatic Adenocarcinoma
por: Skoda, Jan, et al.
Publicado: (2016)

Enhancement of ATRA-induced differentiation of neuroblastoma cells with LOX/COX inhibitors: an expression profiling study
por: Chlapek, Petr, et al.
Publicado: (2010)

New Target for Precision Medicine Treatment of Giant-Cell Tumor of Bone: Sunitinib Is Effective in the Treatment of Neoplastic Stromal Cells with Activated PDGFRβ Signaling
por: Mahdal, Michal, et al.
Publicado: (2021)

Mechanisms of methotrexate resistance in osteosarcoma cell lines and strategies for overcoming this resistance
por: WANG, JIANJUN, et al.
Publicado: (2015)

Prediction of neuroblastoma cell response to treatment with natural or synthetic retinoids using selected protein biomarkers
por: Dobrotkova, Viera, et al.
Publicado: (2019)

Why Differentiation Therapy Sometimes Fails: Molecular Mechanisms of Resistance to Retinoids
por: Chlapek, Petr, et al.
Publicado: (2018)

Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy
por: Dobrotkova, Viera, et al.
Publicado: (2018)

miR-192 suppresses leptomeningeal dissemination of medulloblastoma by modulating cell proliferation and anchoring through the regulation of DHFR, integrins, and CD47
por: Yang, Seung Yeob, et al.
Publicado: (2015)

Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas—Retrospective Analysis of Three Real-Life Clinical Cases—Addressing Issues on Randomization and Customization at the Bedside
por: Polaskova, Kristyna, et al.
Publicado: (2020)

The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy
por: Pavlasova, Gabriela, et al.
Publicado: (2020)

Patient-derived osteosarcoma cells are resistant to methotrexate
por: dos Santos Cavalcanti, Amanda, et al.
Publicado: (2017)

miRNA-24 Gene Sequence, DHFR −829C-T Genotypes, and Methotrexate Response in Mexican Patients with Rheumatoid Arthritis
por: Hernández-Preciado, Martha Rocio, et al.
Publicado: (2019)

Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize
por: Kýr, Michal, et al.
Publicado: (2020)

Expression and characterization of mouse prolactin (mPRL) in CHO dhfr- cells
por: Suzuki, Miriam Fussae, et al.
Publicado: (2014)

Cytotoxicity of poly-guanidine in medulloblastoma cell lines
por: Gallo-Oller, Gabriel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_76qik705jbbqtdg3iu9avgo3t0